Oncolytics Biotech Inc Sustainability Reports

Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company focused on the research and development of oncology treatments. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and gastrointestinal cancers.

Sector: Manufacturing

Country: Canada

Exchange: Toronto Stock Exchange

7 reports from 2010 to 2025

• Oncolytics Biotech Inc 2025 Annual Report on Form 10-K
• Oncolytics Biotech Inc 2024 Form 20-F
• Oncolytics Biotech Inc 2023 Form 20-F
• Oncolytics Biotech Inc 2022 Financial Statements and Management's Discussion and Analysis
• Oncolytics Biotech Inc 2021 Financial Statements and Management's Discussion and Analysis